Natural killer cells in healthy and diseased subjects.
作者信息
Biassoni Roberto, Coligan John E, Moretta Lorenzo
出版信息
J Biomed Biotechnol. 2011;2011:795251. doi: 10.1155/2011/795251. Epub 2011 Aug 29.
Abstract
摘要
相似文献
1
Natural killer cells in healthy and diseased subjects.
J Biomed Biotechnol. 2011;2011:795251. doi: 10.1155/2011/795251. Epub 2011 Aug 29.
2
Killer cell immunoglobulin-like receptors are associated with common variable immune deficiency pathogenesis.
J Allergy Clin Immunol. 2016 Nov;138(5):1495-1498. doi: 10.1016/j.jaci.2016.07.011. Epub 2016 Sep 21.
3
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
PLoS One. 2021 Aug 5;16(8):e0255608. doi: 10.1371/journal.pone.0255608. eCollection 2021.
4
NK cell education: not an on-off switch but a tunable rheostat.
Trends Immunol. 2009 Apr;30(4):143-9. doi: 10.1016/j.it.2009.01.006. Epub 2009 Mar 11.
5
Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection.
Eur J Immunol. 2013 Feb;43(2):480-7. doi: 10.1002/eji.201242389. Epub 2012 Dec 12.
6
Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health.
J Allergy Clin Immunol Pract. 2022 Jul;10(7):1763-1775. doi: 10.1016/j.jaip.2022.04.036. Epub 2022 May 10.
7
Gene-specific PCR typing of killer cell immunoglobulin-like receptors.
Methods Mol Biol. 2013;1034:239-55. doi: 10.1007/978-1-62703-493-7_12.
8
The extreme plasticity of killer cell Ig-like receptor (KIR) haplotypes differentiates rhesus macaques from humans.
Eur J Immunol. 2011 Sep;41(9):2719-28. doi: 10.1002/eji.201141621. Epub 2011 Aug 4.
9
Design and Validation of a Multiplex KIR and HLA Class I Genotyping Method Using Next Generation Sequencing.
Front Immunol. 2018 Dec 19;9:2991. doi: 10.3389/fimmu.2018.02991. eCollection 2018.
10
Association of killer cell immunoglobulin-like receptor genotypes with susceptibility to endometriosis.
Am J Reprod Immunol. 2007 Dec;58(6):481-6. doi: 10.1111/j.1600-0897.2007.00533.x.
本文引用的文献
1
Involvement of activating NK cell receptors and their modulation in pathogen immunity.
J Biomed Biotechnol. 2011;2011:152430. doi: 10.1155/2011/152430. Epub 2011 Aug 11.
2
How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance.
J Biomed Biotechnol. 2011;2011:724607. doi: 10.1155/2011/724607. Epub 2011 Jun 30.
3
Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy.
J Biomed Biotechnol. 2011;2011:861920. doi: 10.1155/2011/861920. Epub 2011 Jun 13.
4
Potential role of NK cells in the pathogenesis of inflammatory bowel disease.
J Biomed Biotechnol. 2011;2011:348530. doi: 10.1155/2011/348530. Epub 2011 Jun 1.
5
NK cells and psoriasis.
J Biomed Biotechnol. 2011;2011:248317. doi: 10.1155/2011/248317. Epub 2011 May 26.
6
The impact of Ly49-NK cell-dependent recognition of MCMV infection on innate and adaptive immune responses.
J Biomed Biotechnol. 2011;2011:641702. doi: 10.1155/2011/641702. Epub 2011 May 22.
7
Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics.
J Biomed Biotechnol. 2011;2011:473097. doi: 10.1155/2011/473097. Epub 2011 May 3.
8
Clinical cancer therapy by NK cells via antibody-dependent cell-mediated cytotoxicity.
J Biomed Biotechnol. 2011;2011:379123. doi: 10.1155/2011/379123. Epub 2011 May 24.
9
WF10 stimulates NK cell cytotoxicity by increasing LFA-1-mediated adhesion to tumor cells.
J Biomed Biotechnol. 2011;2011:436587. doi: 10.1155/2011/436587. Epub 2011 May 3.
10
KIR/HLA interactions and pathogen immunity.
J Biomed Biotechnol. 2011;2011:298348. doi: 10.1155/2011/298348. Epub 2011 May 19.
Zotero 插件